19-38596425-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001042600.3(MAP4K1):āc.2003C>Gā(p.Ser668Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000396 in 1,592,578 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000066 ( 0 hom., cov: 32)
Exomes š: 0.000037 ( 0 hom. )
Consequence
MAP4K1
NM_001042600.3 missense
NM_001042600.3 missense
Scores
2
6
10
Clinical Significance
Conservation
PhyloP100: 1.50
Genes affected
MAP4K1 (HGNC:6863): (mitogen-activated protein kinase kinase kinase kinase 1) Enables ATP binding activity and MAP kinase kinase kinase kinase activity. Involved in several processes, including JNK cascade; cellular response to phorbol 13-acetate 12-myristate; and protein phosphorylation. Located in membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.27187842).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP4K1 | NM_001042600.3 | c.2003C>G | p.Ser668Cys | missense_variant | 26/31 | ENST00000396857.7 | NP_001036065.1 | |
MAP4K1-AS1 | NR_134907.1 | n.79G>C | non_coding_transcript_exon_variant | 1/3 | ||||
MAP4K1 | NM_007181.6 | c.2003C>G | p.Ser668Cys | missense_variant | 26/32 | NP_009112.1 | ||
MAP4K1 | XM_011526404.2 | c.2123C>G | p.Ser708Cys | missense_variant | 27/32 | XP_011524706.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP4K1 | ENST00000396857.7 | c.2003C>G | p.Ser668Cys | missense_variant | 26/31 | 5 | NM_001042600.3 | ENSP00000380066 | P1 | |
MAP4K1-AS1 | ENST00000589557.1 | n.80G>C | non_coding_transcript_exon_variant | 1/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152242Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
10
AN:
152242
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000585 AC: 12AN: 205008Hom.: 0 AF XY: 0.0000442 AC XY: 5AN XY: 113134
GnomAD3 exomes
AF:
AC:
12
AN:
205008
Hom.:
AF XY:
AC XY:
5
AN XY:
113134
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000368 AC: 53AN: 1440218Hom.: 0 Cov.: 32 AF XY: 0.0000377 AC XY: 27AN XY: 715400
GnomAD4 exome
AF:
AC:
53
AN:
1440218
Hom.:
Cov.:
32
AF XY:
AC XY:
27
AN XY:
715400
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000656 AC: 10AN: 152360Hom.: 0 Cov.: 32 AF XY: 0.0000268 AC XY: 2AN XY: 74502
GnomAD4 genome
AF:
AC:
10
AN:
152360
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74502
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
5
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 15, 2023 | The c.2003C>G (p.S668C) alteration is located in exon 26 (coding exon 26) of the MAP4K1 gene. This alteration results from a C to G substitution at nucleotide position 2003, causing the serine (S) at amino acid position 668 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;L
MutationTaster
Benign
D;N;N;N
PrimateAI
Pathogenic
T
PROVEAN
Benign
.;.;N
REVEL
Uncertain
Sift
Uncertain
.;.;D
Sift4G
Uncertain
T;T;T
Polyphen
D;.;D
Vest4
MutPred
Loss of glycosylation at S668 (P = 0.0289);.;Loss of glycosylation at S668 (P = 0.0289);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at